Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G for Jasper Therapeutics, Inc. Voting Common Stock (JSPR).
- Disclosed ownership: 7%.
- Date of event: 31 Dec 2025.
MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G Report for Jasper Therapeutics, Inc. Voting Common Stock (JSPR)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- JSPR
- Shares outstanding
- 28,139,786 shares
- Disclosed Ownership
- 1,969,785 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G
- Filing time
- 11 Feb 2026, 13:38:43 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 07 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 7% ownership in Jasper Therapeutics, Inc. Voting Common Stock (JSPR) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 07 Nov 2025.
- Current filing was accepted on 11 Feb 2026, 13:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 7% | 1,969,785 | 0 | 1,969,585 | Chris O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 6.8% | 1,903,420 | 0 | 1,903,420 | Chris O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |